BIRC5 and pituitary tumor: Also, the comparison of survivin and splice variant expression in GH-secreting tumors preoperatively treated with somatostatin analogues with other pituitary tumors, revealed that their expression is similar in all studied cases (survivin P = 0.5397; ∆Ex3 P = 0.1851; 2β, P = 0.2752).